Navigation Links
Adeona Reports Third Quarter 2011 Financial Results
Date:11/14/2011

a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the expanded opportunities that exist for us, the planned commercial launch of wellZin, as well as the development of reaZin, our ability to obtain INDs in a timely manner for some of our drug candidates, the ability of our current cash position to meet our planned needs for the next 12 month, and the anticipated enrollment, timing or results of our planned Alzheimer's, ALS or multiple sclerosis cognition clinical trials. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, our failure to successfully commercialize wellZin for the common cold, develop reaZin as a medical food for the dietary management of zinc deficiency associated with Alzheimer's disease, develop AEN-100 as a treatment for Alzheimer's or ALS, or develop Trimesta as a treatment for relapses or cognitive dysfunction in multiple sclerosis, the failure of reaZin or wellZin to be accepted for either use, failure of future clinical trials of any of our drug candidates to be enrolled in and completed in the anticipated time or to achieve the desired results, the failure of Meda to commercialize flupirtine and to make any other payments under the sublicense agreement, and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2010 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Adeona undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
2. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
3. Adeona Appoints Jeff Lucero Riley as Independent Chairman
4. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
5. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
6. Adeona Appoints George A. Eby to Scientific Advisory Board
7. Adeona Reports Second Quarter 2011 Financial Results
8. Adeona to Host Second Quarter 2011 Investor Conference Call
9. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
10. Adeona Reports 1st Quarter 2011 Financial Results
11. Adeona to Host First Quarter 2011 Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... it has completed the sale to Galderma of all ... or held by Valeant for $1.4 billion in cash, ... which recently completed its acquisition of Galderma. ... our products to a company that is firmly committed ...
(Date:7/10/2014)... BURLINGTON, Mass. , July 10, 2014 /PRNewswire/ ... three-quarters of surveyed infectious disease (ID) specialists are ... Medicines Company,s Orbactiv (oritavancin) for use as OPAT, ... to prescribe these agents to their hospital inpatients. ... percent) of OPAT patients are initiated on OPAT ...
(Date:7/10/2014)... 2014 CVS Caremark Corporation (NYSE: CVS ... a quarterly dividend of $0.275 (27.5 cents) per share on ... 1, 2014, to holders of record on July 21, 2014. ... is dedicated to helping people on their path to better ... the United States . Through the company,s more than ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 17 The Department of,Justice announced today that ... CEO,Roundtable on Cancer (CRC) to develop and publicize ... cancer treatments. The Department said,the language is not ... to help,increase efficiency in contract negotiations, potentially reducing ...
... (OTC Bulletin Board: BSTC), a biopharmaceutical company,developing first ... of a U.S. Phase IIb clinical trial in ... its partner Auxlium,Pharmaceuticals, Inc., "We are very ... this trial,into a Phase IIb based on our ...
Cached Medicine Technology:Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease 3
(Date:7/11/2014)... Anterior Cruciate Ligament (ACL) happens all too frequently, however ... Orthopaedic Society for Sports Medicine,s (AOSSM) Annual Meeting suggests ... may minimize the chance of a future ACL tear. ... factors such as, age, activity level and type of ... said lead author, Christopher C. Kaeding, MD of the ...
(Date:7/11/2014)... NY (PRWEB) July 11, 2014 Wild by ... is proud to announce they are opening a fifth store ... Wild by Nature offers one of the largest selections of ... people diagnosed with celiac disease, these stores have become a ... gluten-free diet. , Gluten sensitivity, and gluten intolerance, is a ...
(Date:7/11/2014)... BellasDress, the experienced dressmaker in the ... suppliers when it comes to beach wedding dresses ... of beach wedding outfits in its online shop. Included ... outfits. , BellasDress has been considered as one ... to the company’s senior spokesman, BellasDress provides superb special ...
(Date:7/11/2014)... Growing old was thought of as a fate that was ... was shown that many of the “myths” people associate with ... out, the elderly can still live quite as fruitfully as their ... time in the world, older people also need to live a ... the twilight of their lives. This is why Guy Coalter, the ...
(Date:7/11/2014)... July 11, 2014 Plasma resource reserves ... products industry. Although the closure of 16 plasma collection ... to domestic blood products market, the total plasma volume ... on year and total lot release volume declined by ... stock consumption, insufficient utilization of new plasma stations and ...
Breaking Medicine News(10 mins):Health News:Wild by Nature Opens New Location 2Health News:BellasDress Emerges As Popular Online Supplier Of 2014 Beach Wedding Dresses 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4
... of your New Year resolutions, The Alliance for Aging Research// ... of both physical as well as mental exercise to stay ... nonprofit Alliance for Aging Research said, "There is a lot ... prevent or lessen the cognitive decline that often comes with ...
... habit of offering fruit juices and sugar added beverages ... better to avoid sugary drinks in cups with sippers ... the sipper attached. The American Academy of Pediatric Dentistry (AAPD) ... cups do help to avoid liquids from spilling over from ...
... for patients in ICU by adhering to simple techniques ... infections. // ICUs can become thoroughly aseptic by ensuring ... and catheters. A detailed report was made by experts ... the report are published in New England Journal of ...
... parents to encourage their children to put away the video ... AMA Vice President, Dr Choong-Siew Yong, said today. ... soccer balls and tennis racquets are a great way to ... ,“Swimming or horse-riding lessons, bicycle outings, backyard cricket, or just ...
... junta, left for Singapore to receive treatment for an intestinal ... who has led Myanmar's junta - the self-styled State Peace ... the country Sunday on a special flight arranged by businessman ... ,An informed source in the government said Than Shwe, ailing ...
... the calories a person consumes can prevent, or at least ... suggests// that body composition – whether a person is ... risks. ,In other words, how the body ... than how many or how few calories are consumed—a finding ...
Cached Medicine News:Health News:Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU 2Health News:Keep Kids Active in the Holidays 2Health News:Body Composition Is Key Player in Controlling Cancer Risks 2
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features: Eppendorf ...
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
... a fully adjustable, air-displacement pipette with a ... latest member of the Pipetman family, sharing ... and precision. We also added a number ... customers. Eight models cover the full range ...
Medicine Products: